You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
白雲山(600332.SH):廣東省高院駁回廣藥集團“與加多寶、樂潤百貨不正當競爭糾紛一案”再審申請
格隆匯 06-19 16:37

格隆匯6月19日丨白雲山(600332.SH)公佈,公司控股股東廣州醫藥集團有限公司(“廣藥集團”)及全資子公司廣州王老吉大健康產業有限公司(“王老吉大健康公司”)於2020年6月18日收到中華人民共和國最高人民法院(“最高院”)關於被申請人廣東加多寶飲料食品有限公司(“廣東加多寶”)及原審被告廣東樂潤百貨有限公司(“樂潤百貨”)與一審原告、二審被上訴人王老吉大健康公司及廣藥集團“不正當競爭糾紛一案”的再審判決書【(2019)最高法民申579號】《民事裁定書》(“裁定書”),現將相關情況公告如下:

一、案件的基本情況

茲提述本公司日期為2015年12月3日、編號為“2015-102”的一審判決公告,日期為2017年11月14日、編號為“2017-067”的二審判決公告,內容有關本公司控股股東廣藥集團及全資子公司王老吉大健康公司與廣東加多寶、樂潤百貨“不正當競爭糾紛一案”的一審【(2013)穗中法知民初字第619號】及二審【(2016)粵民終303號】判決情況的事宜。

再審申請人廣藥集團不服廣東省高級人民法院【(2016)粵民終303號】民事判決,向最高院申請再審。

二、案件再審判決結果

根據裁定書,本案的再審申請裁定結果如下:駁回廣藥集團的再審申請。

三、對本公司的影響

預計本次判決對本公司本期或期後利潤不會產生影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account